Hepatocyte Growth Factor Is a Regulator of Monocyte-Macrophage Function1
暂无分享,去创建一个
L. Naldini | F. Galimi | P. Comoglio | S. Giordano | E. Cottone | N. Arena | C. Boccaccio | E. Vigna
[1] Youhua Liu. Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms. , 1999, American journal of physiology. Renal physiology.
[2] P. Schirmacher,et al. Neoexpression of the c-met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes. , 1997, Blood.
[3] T. Evans,et al. Developmental biology of hematopoiesis. , 1997, Hematology/oncology clinics of North America.
[4] F. Blasi. uPA, uPAR, PAI-1: key intersection of proteolytic, adhesive and chemotactic highways? , 1997, Immunology today.
[5] Q. Chen,et al. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[6] A. Ullrich,et al. Rapid and Long Term Effects of Protein Kinase C on Receptor Tyrosine Kinase Phosphorylation and Degradation (*) , 1995, The Journal of Biological Chemistry.
[7] G. Michalopoulos,et al. Mini-review the Many Faces of Hepatocyte Growth Factor: from Hepatopoiesis to Hematopoiesis Structural Properties of Hgf the Hgf Receptor , 1995 .
[8] A. Bardelli,et al. Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction (*) , 1995, The Journal of Biological Chemistry.
[9] F. Galimi,et al. Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors , 1994, The Journal of cell biology.
[10] F. Galimi,et al. Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF. , 1994, The Journal of biological chemistry.
[11] S. Giordano,et al. Structure and inducible regulation of the human MET promoter. , 1994, The Journal of biological chemistry.
[12] A. Bardelli,et al. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family , 1994, Cell.
[13] K. Matsumoto,et al. Hepatocyte growth factor specifically binds to sulfoglycolipids. , 1994, The Journal of biological chemistry.
[14] L. McManus,et al. PAF molecular heterogeneity: pathobiological implications. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[15] C. Birchmeier,et al. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development , 1993, The Journal of cell biology.
[16] H. Koyama,et al. Regulation of release of hepatocyte growth factor from human promyelocytic leukemia cells, HL-60, by 1,25-dihydroxyvitamin D3, 12-O-tetradecanoylphorbol 13-acetate, and dibutyryl cyclic adenosine monophosphate. , 1993, Blood.
[17] P. Comoglio,et al. Hepatocyte growth factor/scatter factor stimulates the Ras-guanine nucleotide exchanger. , 1993, The Journal of biological chemistry.
[18] H. Kleinman,et al. Scatter factor induces blood vessel formation in vivo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[19] E Medico,et al. Transfer of motogenic and invasive response to scatter factor/hepatocyte growth factor by transfection of human MET protooncogene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[20] W. Birchmeier,et al. Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor. , 1992, The EMBO journal.
[21] L. Naldini,et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth , 1992, The Journal of cell biology.
[22] K. Miyazawa,et al. Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer. , 1992, The Journal of biological chemistry.
[23] A. Bardelli,et al. Autophosphorylation promotes complex formation of recombinant hepatocyte growth factor receptor with cytoplasmic effectors containing SH2 domains. , 1992, Oncogene.
[24] P. Godowski,et al. Structure‐function analysis of hepatocyte growth factor: identification of variants that lack mitogenic activity yet retain high affinity receptor binding. , 1992, The EMBO journal.
[25] P. Comoglio,et al. C-terminal truncated forms of Met, the hepatocyte growth factor receptor , 1991, Molecular and cellular biology.
[26] L. Orci,et al. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor , 1991, Cell.
[27] L. Cantley,et al. The tyrosine-phosphorylated hepatocyte growth factor/scatter factor receptor associates with phosphatidylinositol 3-kinase. , 1991, The Journal of biological chemistry.
[28] A. Bardelli,et al. Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor. , 1991, The EMBO journal.
[29] P. Comoglio,et al. The receptor encoded by the human C‐MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors , 1991, International journal of cancer.
[30] W. Birchmeier,et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[31] T. Nakamura,et al. Identification and change in the receptor for hepatocyte growth factor in rat liver after partial hepatectomy or induced hepatitis. , 1991, Biochemical and biophysical research communications.
[32] P. Comoglio,et al. c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. , 1991, Oncogene.
[33] G. Michalopoulos,et al. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. , 1991, Oncogene.
[34] J Vandekerckhove,et al. Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells , 1990, The Journal of cell biology.
[35] K. Tashiro,et al. Molecular cloning and expression of human hepatocyte growth factor , 1989, Nature.
[36] C. Cooper,et al. Biosynthesis of the protein encoded by the c-met proto-oncogene. , 1989, Oncogene.
[37] J. Enghild,et al. NH2-terminal amino acid sequence of rabbit hepatopoietin A, a heparin-binding polypeptide growth factor for hepatocytes. , 1989, Biochemical and biophysical research communications.
[38] C. Cooper,et al. Tyrosine kinase receptor indistinguishable from the c-met protein , 1989, Nature.
[39] A. Mantovani,et al. Granulocyte- and granulocyte– macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate , 1989, Nature.
[40] M. Stratton,et al. Structure of the met protein and variation of met protein kinase activity among human tumour cell lines. , 1988, British Journal of Cancer.
[41] C. Dinarello,et al. Interleukin-1 stimulates diacylglycerol production in T lymphocytes by a novel mechanism , 1988, Cell.
[42] Michael Stoker,et al. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility , 1987, Nature.
[43] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[44] G. Michalopoulos,et al. Control of hepatocyte replication by two serum factors. , 1984, Cancer research.
[45] D. Belin,et al. Concomitant secretion of prourokinase and of a plasminogen activator- specific inhibitor by cultured human monocytes-macrophages , 1984, The Journal of experimental medicine.
[46] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[47] J. Bousquet,et al. Updates on cells and cytokines : monocytes , 1998 .
[48] T. Suzuki,et al. Lipopolysaccharide receptors and signal transduction pathways in mononuclear phagocytes. , 1992, Current topics in microbiology and immunology.
[49] A. Mantovani,et al. Interaction between fibrinogen and cultured endothelial cells. Induction of migration and specific binding. , 1985, The Journal of clinical investigation.